论文部分内容阅读
乳腺癌是危害妇女健康的主要恶性肿瘤,我国虽是乳腺癌的低发区,但其发病率逐年上升。手术、化疗及内分泌治疗的综合应用是乳腺癌的主要治疗手段。吡柔比星(p iravu-b ic in,THP)是一种半合成蒽环类抗癌药,具有较强的抗癌活性,近年来的研究表明,其对多种肿瘤具有明显疗效,以蒽环
Breast cancer is a major malignant tumor that harms women’s health. Although China is a low-risk area of breast cancer, its incidence has increased year by year. Comprehensive application of surgery, chemotherapy and endocrine therapy is the main treatment for breast cancer. Piravu-b ic in (THP) is a semi-synthetic anthracycline anticancer drug with strong anti-cancer activity. Recent studies have shown that it has obvious curative effect on many kinds of tumors. Ring